Developer docs
API playgroundTry for free, no card

Search company profiles

ATMP Consulting Group

Full company profile

uuid02m1nu4

Namestring
ATMP Consulting Group
Legal namestring
ATMP Consulting Group
Websiteurl
atmpconsult.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

ATMP Consulting Group is a privately held, founder-led boutique consultancy founded in 2025 and headquartered in Gainesville, Florida, that delivers expert advisory services to organizations developing cell and gene therapies, biologics, and vaccines. Its core offerings span CMC Leadership and Strategy, Manufacturing and CDMO Oversight, Technical Diligence, Product and Process Development across in vivo and ex vivo platforms (AAV, Adenovirus, Lentivirus, Retrovirus, and oncolytic viruses), and Facility Design and Oversight, with regulatory support from Interact and Pre-IND through IND, BLA, and MAA filings in the US, EU, and international markets.

The firm operates a consortium model that aggregates subject matter experts across CMC, Quality, Non-clinical, Regulatory, and Analytical disciplines, enabling multi-discipline engagements without the client coordinating multiple vendors. Its founding team, led by Scott Cross (Founder and CEO, formerly Head of Gene Therapy CMC at Dark Horse Consulting Group), includes Katie Miller (Sr. Principal, 30+ years industry, 15+ years in CGT, previously VP/Head of Quality at Sonoma Biotherapeutics and VP/Global Head of Analytics at Bayer) and Malachi Wickman (Principal Consultant, 8 years CGT experience from American Red Cross Cell & Gene Therapy Solutions and Dark Horse Consulting Group). The company has also formed a strategic alliance with PQP Group, extending its capabilities into UK and EU regulatory licensing, QP release, secondary packaging, and depot/logistics services for advanced therapy products.

Revenue is generated through professional services consulting engagements sold on a sales-led and enterprise field sales basis, with a free consultation offered as the entry point. No pricing, contract values, or revenue figures are publicly disclosed, and no funding rounds or external institutional investment are recorded. Marketing relies on the firm website and LinkedIn presence, and the firm serves enterprise clients primarily across North America, the UK, and the EU.

Short descriptiontext

ATMP Consulting Group is a Gainesville, Florida-based boutique consultancy founded in 2025 that provides CMC, manufacturing, regulatory, and facility design advisory services to cell and gene therapy, biologics, and vaccine developers through a consortium of senior SMEs and a strategic alliance with PQP Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGainesville, United States
HQ citystring
Gainesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell gene therapy consulting, CMC strategy consulting, CDMO oversight services, biopharmaceutical regulatory consulting, advanced therapy manufacturing consulting
Industry2 codes
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAAACAM
Gene Therapy Regulatory, Pharmacovigilance & Clinical Operations Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
NAICS code2 codes
  • Management, Scientific, and Technical Consulting Services5416
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Commercial Physical & Biological Research8731
Product category
Biopharmaceutical Consulting
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services
TypeProfessional Services
Description

Expert strategic and technical guidance across advanced therapies, biologics, vaccines and peripheral industries. Services address CMC, manufacturing, analytical and regulatory challenges from early development through commercialization.

atmpconsult.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Free Consultation
ModelOtherBilling cadencePay-as-you-go
Notes

Initial consultation offered at no charge to assess client needs and challenges.

atmpconsult.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ATMP Consulting Group provides expert consulting services across the cell and gene therapy lifecycle, including CMC leadership and strategy, manufacturing and CDMO oversight, technical diligence, product and process development, and facility design. The firm delivers these services through a consortium model that connects clients with subject matter experts across CMC, Quality, Non-clinical, Regulatory, and Analytical disciplines, supporting advanced therapy sponsors from early development through commercialization.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ATMP Consulting Group offers a suite of consulting services for the cell and gene therapy industry. The core offerings include CMC Leadership and Strategy, Manufacturing and CDMO Oversight, Technical Diligence, Product and Process Development, and Facility Design and Oversight. These services are delivered through a consortium model that enables subject matter experts to collaborate across disciplines including CMC, Quality, Non-clinical, Regulatory, and Analytical areas. The company also operates through a strategic alliance with PQP Group to expand global quality leadership and operational capabilities.

Product and service1 record
1CMC Leadership and Strategy
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1PQP Group
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Strategic alliance combining PQP Group's global quality leadership and operational experience with ATMP Consulting Group's deep hands-on expertise across the cell and gene therapy lifecycle. The alliance enables clients to access a unified network of subject matter experts with combined capabilities supporting both US and EU regulatory strategy, CMC authorship, technical, Quality and supply chain solutions for clinical and commercial programs. PQP Group brings licensed operations across the UK and EU including import, secondary packaging, QP release and depot and logistic services for advanced therapy products.

atmpconsult.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global regulatory and CMC consulting firm serving pharma and biotech (now part of Cencora). Comparable to ATMP in regulatory strategy and CMC authoring across development phases, but with a far broader therapeutic footprint than ATMP's CGT specialization.

2PQP Group
TypeDirect peer
Description

UK/EU-based consulting firm specializing in quality, compliance, and risk-management solutions for pharma, biotech, and cell/gene therapy organizations. Strategic alliance partner of ATMP Consulting Group with overlapping service scope but distinct geographic core.

TypeBroad incumbent
Description

Engineering, architecture, and consulting firm specializing in life sciences facility design and construction. Directly comparable to ATMP's facility design and oversight offering for advanced therapy manufacturing facilities, though broader in client base.

TypeBroad incumbent
Description

Life sciences consulting firm providing regulatory, compliance, clinical, and quality services across pharma and biotech. Overlaps with ATMP in regulatory strategy and quality/CMC consulting but is broader in therapeutic and service scope.

TypeDirect peer
Description

The leading dedicated cell and gene therapy consulting firm; ATMP's founder Scott Cross previously served there as Head of Gene Therapy CMC and Senior Principal. Directly comparable across CMC, manufacturing oversight, regulatory, and facility design services for CGT sponsors.

TypeBroad incumbent
Description

Consulting firm providing GxP compliance, validation, and engineering services to pharma/biotech manufacturers. Comparable to ATMP's facility design/oversight and CDMO oversight offerings, particularly for build-out and qualification projects.

TypeDirect peer
Description

Biotech consulting firm offering CMC, regulatory, and quality services to cell, gene, and biologic therapy developers. Closely comparable niche peer to ATMP's CGT-focused service portfolio.

TypeBroad incumbent
Description

Life sciences consulting practice serving biotech and pharma across CMC, regulatory, and commercial strategy. Comparable to ATMP in CMC and regulatory advisory but operates as a broader management consultancy rather than a CGT specialist.

TypeDirect peer
Description

Consulting firm specializing in bioprocess development, manufacturing, and CMC strategy for biologics and advanced therapies. Directly comparable to ATMP's product/process development, CMC, and CDMO oversight service lines.

TypeEmerging player
Description

Life sciences consulting firm providing quality assurance, regulatory, and compliance services to pharma and biotech. Comparable to ATMP in regulatory and quality consulting for biologics and CGT developers, with similar boutique scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ATMP Consulting Group

Biopharmaceutical Consultingatmpconsult.com

ATMP Consulting Group is a Gainesville, Florida-based boutique consultancy founded in 2025 that provides CMC, manufacturing, regulatory, and facility design advisory services to cell and gene therapy, biologics, and vaccine developers through a consortium of senior SMEs and a strategic alliance with PQP Group.

What ATMP Consulting Group does

ATMP Consulting Group is a privately held, founder-led boutique consultancy founded in 2025 and headquartered in Gainesville, Florida, that delivers expert advisory services to organizations developing cell and gene therapies, biologics, and vaccines. Its core offerings span CMC Leadership and Strategy, Manufacturing and CDMO Oversight, Technical Diligence, Product and Process Development across in vivo and ex vivo platforms (AAV, Adenovirus, Lentivirus, Retrovirus, and oncolytic viruses), and Facility Design and Oversight, with regulatory support from Interact and Pre-IND through IND, BLA, and MAA filings in the US, EU, and international markets.

The firm operates a consortium model that aggregates subject matter experts across CMC, Quality, Non-clinical, Regulatory, and Analytical disciplines, enabling multi-discipline engagements without the client coordinating multiple vendors. Its founding team, led by Scott Cross (Founder and CEO, formerly Head of Gene Therapy CMC at Dark Horse Consulting Group), includes Katie Miller (Sr. Principal, 30+ years industry, 15+ years in CGT, previously VP/Head of Quality at Sonoma Biotherapeutics and VP/Global Head of Analytics at Bayer) and Malachi Wickman (Principal Consultant, 8 years CGT experience from American Red Cross Cell & Gene Therapy Solutions and Dark Horse Consulting Group). The company has also formed a strategic alliance with PQP Group, extending its capabilities into UK and EU regulatory licensing, QP release, secondary packaging, and depot/logistics services for advanced therapy products.

Revenue is generated through professional services consulting engagements sold on a sales-led and enterprise field sales basis, with a free consultation offered as the entry point. No pricing, contract values, or revenue figures are publicly disclosed, and no funding rounds or external institutional investment are recorded. Marketing relies on the firm website and LinkedIn presence, and the firm serves enterprise clients primarily across North America, the UK, and the EU.

ATMP Consulting Group firmographics

Firmographics
Name
ATMP Consulting Group
Legal name
ATMP Consulting Group
Website
https://atmpconsult.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
ATMP Consulting Group is a Gainesville, Florida-based boutique consultancy founded in 2025 that provides CMC, manufacturing, regulatory, and facility design advisory services to cell and gene therapy, biologics, and vaccine developers through a consortium of senior SMEs and a strategic alliance with PQP Group.
Ownership category
akta.pro rank

ATMP Consulting Group industry classification

Industry
Product category
Biopharmaceutical Consulting
NAICS
Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAAACAM
Gene Therapy Regulatory, Pharmacovigilance & Clinical Operations Services
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)

Keywords

  • Cell gene therapy consulting
  • CMC strategy consulting
  • CDMO oversight services
  • Biopharmaceutical regulatory consulting
  • Advanced therapy manufacturing consulting

Where ATMP Consulting Group is headquartered

Location

Headquarters

HQ city
Gainesville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ATMP Consulting Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations

Revenue model

  1. Consulting Services: Expert strategic and technical guidance across advanced therapies, biologics, vaccines and peripheral industries. Services address CMC, manufacturing, analytical and regulatory challenges from early development through commercialization.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goFree Consultation

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

ATMP Consulting Group product offering

Product offering

Core offering

ATMP Consulting Group provides expert consulting services across the cell and gene therapy lifecycle, including CMC leadership and strategy, manufacturing and CDMO oversight, technical diligence, product and process development, and facility design. The firm delivers these services through a consortium model that connects clients with subject matter experts across CMC, Quality, Non-clinical, Regulatory, and Analytical disciplines, supporting advanced therapy sponsors from early development through commercialization.

Product overview

ATMP Consulting Group offers a suite of consulting services for the cell and gene therapy industry. The core offerings include CMC Leadership and Strategy, Manufacturing and CDMO Oversight, Technical Diligence, Product and Process Development, and Facility Design and Oversight. These services are delivered through a consortium model that enables subject matter experts to collaborate across disciplines including CMC, Quality, Non-clinical, Regulatory, and Analytical areas. The company also operates through a strategic alliance with PQP Group to expand global quality leadership and operational capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • CMC Leadership and Strategy

Companies that use ATMP Consulting Group

Customer profile

Segments3 records

Ideal customer profiles3 records

ATMP Consulting Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

ATMP Consulting Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • PQP GroupcoreStrategic or Co-development Partner · 1 January 2025Strategic alliance combining PQP Group's global quality leadership and operational experience with ATMP Consulting Group's deep hands-on expertise across the cell and gene therapy lifecycle. The alliance enables clients to access a unified network of subject matter experts with combined capabilities supporting both US and EU regulatory strategy, CMC authorship, technical, Quality and supply chain solutions for clinical and commercial programs. PQP Group brings licensed operations across the UK and EU including import, secondary packaging, QP release and depot and logistic services for advanced therapy products.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

ATMP Consulting Group competitors and assessment

Company assessment

Broad incumbents

  • PharmaLex: Global regulatory and CMC consulting firm serving pharma and biotech (now part of Cencora). Comparable to ATMP in regulatory strategy and CMC authoring across development phases, but with a far broader therapeutic footprint than ATMP's CGT specialization.
  • CRB Group: Engineering, architecture, and consulting firm specializing in life sciences facility design and construction. Directly comparable to ATMP's facility design and oversight offering for advanced therapy manufacturing facilities, though broader in client base.
  • ProPharma Group: Life sciences consulting firm providing regulatory, compliance, clinical, and quality services across pharma and biotech. Overlaps with ATMP in regulatory strategy and quality/CMC consulting but is broader in therapeutic and service scope.
  • Pharmatech Associates: Consulting firm providing GxP compliance, validation, and engineering services to pharma/biotech manufacturers. Comparable to ATMP's facility design/oversight and CDMO oversight offerings, particularly for build-out and qualification projects.
  • Latham BioPharm Group: Life sciences consulting practice serving biotech and pharma across CMC, regulatory, and commercial strategy. Comparable to ATMP in CMC and regulatory advisory but operates as a broader management consultancy rather than a CGT specialist.

Direct peers

  • PQP Group: UK/EU-based consulting firm specializing in quality, compliance, and risk-management solutions for pharma, biotech, and cell/gene therapy organizations. Strategic alliance partner of ATMP Consulting Group with overlapping service scope but distinct geographic core.
  • Dark Horse Consulting Group: The leading dedicated cell and gene therapy consulting firm; ATMP's founder Scott Cross previously served there as Head of Gene Therapy CMC and Senior Principal. Directly comparable across CMC, manufacturing oversight, regulatory, and facility design services for CGT sponsors.
  • Biologic Consulting: Biotech consulting firm offering CMC, regulatory, and quality services to cell, gene, and biologic therapy developers. Closely comparable niche peer to ATMP's CGT-focused service portfolio.
  • BioProcess Technology Consultants (BPTC): Consulting firm specializing in bioprocess development, manufacturing, and CMC strategy for biologics and advanced therapies. Directly comparable to ATMP's product/process development, CMC, and CDMO oversight service lines.

Emerging players

  • GXP-Compliance: Life sciences consulting firm providing quality assurance, regulatory, and compliance services to pharma and biotech. Comparable to ATMP in regulatory and quality consulting for biologics and CGT developers, with similar boutique scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

ATMP Consulting Group social profiles

Digital presence

ATMP Consulting Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ATMP Consulting Group leadership team

Management profile

Number of profiles

Profiles4 records

ATMP Consulting Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ATMP Consulting Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ATMP Consulting Group

What does ATMP Consulting Group do?

ATMP Consulting Group provides expert consulting services across the cell and gene therapy lifecycle, including CMC leadership and strategy, manufacturing and CDMO oversight, technical diligence, product and process development, and facility design. The firm delivers these services through a consortium model that connects clients with subject matter experts across CMC, Quality, Non-clinical, Regulatory, and Analytical disciplines, supporting advanced therapy sponsors from early development through commercialization.

Is ATMP Consulting Group a public or private company?

ATMP Consulting Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ATMP Consulting Group founded?

ATMP Consulting Group was founded in 2025. It employs 1 to 10 people.

Where is ATMP Consulting Group based?

ATMP Consulting Group is headquartered in Gainesville, United States, in the North America region.

How does ATMP Consulting Group make money?

One revenue line is on record: consulting Services.

Who are ATMP Consulting Group's main competitors?

Broad incumbents on record are PharmaLex, CRB Group, ProPharma Group, Pharmatech Associates and Latham BioPharm Group. Direct peers are PQP Group, Dark Horse Consulting Group, Biologic Consulting and BioProcess Technology Consultants (BPTC). GXP-Compliance is listed as an emerging player.

Does ATMP Consulting Group have an API?

No public API is recorded for ATMP Consulting Group.

What industry is ATMP Consulting Group in?

ATMP Consulting Group's product category is Biopharmaceutical Consulting. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLAAACAM, Gene Therapy Regulatory, Pharmacovigilance & Clinical Operations Services. Its NAICS code is 5416 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales